Clinical Trial Detail

NCT ID NCT04457284
Title Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

colorectal adenocarcinoma

Therapies

Cisplatin + Nivolumab + Temozolomide

Age Groups: adult senior

Additional content available in CKB BOOST